Skip to main content
Top
Published in: Inflammation Research 2/2012

01-02-2012 | Original Research Paper

Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis

Authors: Young Ho Lee, Hye-Soon Lee, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song

Published in: Inflammation Research | Issue 2/2012

Login to get access

Abstract

Objective

To determine whether endothelial nitric oxide synthase (eNOS) polymorphisms confer susceptibility to systemic lupus erythematosus (SLE).

Methods

A meta-analysis was conducted on the associations between the 4b/a, G894T, and C786T polymorphisms of eNOS and SLE and lupus nephritis (LN) (when available) using (1) the allele contrast, (2) the recessive, (3) the dominant, and (4) the additive models.

Results

A total of eight studies, which included 1,297 cases and 1,214 controls, were included in the meta-analysis. Meta-analysis showed no association between SLE and the 4b/a polymorphism in any study subjects. Stratification by presence of LN indicated a significant association between the a allele and the aa + ab genotype of the 4b/a polymorphism and LN in SLE patients [odds ratio (OR) = 2.125, 95% confidence interval (CI) = 1.289–3.054, p = 0.003; OR = 2.655, 95% CI = 1.509–4.671, p = 0.001]. No association was found between SLE and the G894T polymorphism using the allelic, recessive, or dominant, or additive models. Meta-analysis of the T786C polymorphism showed a tendency to an association between the TT genotype and SLE (OR = 1.220, 95% CI = 1.000–1.489, p = 0.050), and meta-analysis of the TT versus CC genotype of the C786T polymorphism in group in Hardy–Weinberg equilibrium revealed a significant association between the TT genotype and SLE (OR = 1.643, 95% CI = 1.021–2.644, p = 0.041).

Conclusions

This meta-analysis of published studies shows that the 4b/a polymorphism may be associated with the development of LN, and the C786T polymorphism may be associated with SLE susceptibility.
Literature
1.
go back to reference Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet. 2005;118:434–43.PubMedCrossRef Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet. 2005;118:434–43.PubMedCrossRef
2.
go back to reference Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study. Atherosclerosis. 2000;150:179–85.PubMedCrossRef Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study. Atherosclerosis. 2000;150:179–85.PubMedCrossRef
3.
go back to reference Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;97:2832–5.PubMedCrossRef Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;97:2832–5.PubMedCrossRef
4.
go back to reference Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190–3.PubMedCrossRef Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190–3.PubMedCrossRef
5.
go back to reference Alfadhli S, AlTamimy B, AlSaeid K, Haider M. Endothelial nitric oxide synthase gene haplotype association with systemic lupus erythematosus. Lupus. 2011;20:700–8.PubMedCrossRef Alfadhli S, AlTamimy B, AlSaeid K, Haider M. Endothelial nitric oxide synthase gene haplotype association with systemic lupus erythematosus. Lupus. 2011;20:700–8.PubMedCrossRef
6.
go back to reference Li X, An J, Guo R, Jin Z, Li Y, Zhao Y, et al. Association of the genetic polymorphisms of the ACE gene and the eNOS gene with lupus nephropathy in northern Chinese population. BMC Med Genet. 2010;11:94.PubMedCrossRef Li X, An J, Guo R, Jin Z, Li Y, Zhao Y, et al. Association of the genetic polymorphisms of the ACE gene and the eNOS gene with lupus nephropathy in northern Chinese population. BMC Med Genet. 2010;11:94.PubMedCrossRef
7.
go back to reference Tang FY, Xie XW, Ling GH, Liu FY. Endothelial nitric oxide synthase and nicotinamide adenosine dinucleotide phosphate oxidase p22phox gene (C242T) polymorphisms and systemic lupus erythematosus in a Chinese population. Lupus. 2010;19:192–6.PubMedCrossRef Tang FY, Xie XW, Ling GH, Liu FY. Endothelial nitric oxide synthase and nicotinamide adenosine dinucleotide phosphate oxidase p22phox gene (C242T) polymorphisms and systemic lupus erythematosus in a Chinese population. Lupus. 2010;19:192–6.PubMedCrossRef
8.
go back to reference Mucenic T, Brenol JC, Bredemeier M, Paiva Dos Santos B, Chies JA, Monticielo OA, et al. Glu298Asp eNOS polymorphism is not associated with SLE. Lupus. 2009;18:448–51.PubMedCrossRef Mucenic T, Brenol JC, Bredemeier M, Paiva Dos Santos B, Chies JA, Monticielo OA, et al. Glu298Asp eNOS polymorphism is not associated with SLE. Lupus. 2009;18:448–51.PubMedCrossRef
9.
go back to reference Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, et al. Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus. 2007;16:867–74.PubMedCrossRef Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, et al. Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus. 2007;16:867–74.PubMedCrossRef
10.
go back to reference Serrano NC, Paez C, Correa PA, Anaya JM. Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol. 2004;31:2163–8.PubMed Serrano NC, Paez C, Correa PA, Anaya JM. Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J Rheumatol. 2004;31:2163–8.PubMed
11.
go back to reference Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol. 2004;31:1756–62.PubMed Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol. 2004;31:1756–62.PubMed
12.
go back to reference Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus. 2004;13:188–91.PubMedCrossRef Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus. 2004;13:188–91.PubMedCrossRef
13.
go back to reference Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford). 2007;46:49–56.CrossRef Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford). 2007;46:49–56.CrossRef
14.
go back to reference Lee YH, Witte T, Momot T, Schmidt RE, Kaufman KM, Harley JB, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta-analysis. Arthritis Rheum. 2005;52:3966–74.PubMedCrossRef Lee YH, Witte T, Momot T, Schmidt RE, Kaufman KM, Harley JB, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta-analysis. Arthritis Rheum. 2005;52:3966–74.PubMedCrossRef
15.
go back to reference Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter –308A/G polymorphism and SLE susceptibility. Eur J Hum Genet. 2006;14:364–71.PubMedCrossRef Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter –308A/G polymorphism and SLE susceptibility. Eur J Hum Genet. 2006;14:364–71.PubMedCrossRef
16.
17.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
18.
19.
go back to reference Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41–5.PubMedCrossRef Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41–5.PubMedCrossRef
20.
go back to reference Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol. 1998;81:83–6.PubMedCrossRef Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol. 1998;81:83–6.PubMedCrossRef
21.
go back to reference Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol. 2001;37:517–20.PubMedCrossRef Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol. 2001;37:517–20.PubMedCrossRef
22.
go back to reference Salvarani C, Boiardi L, Casali B, Olivieri I, Ciancio G, Cantini F, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet’s disease. J Rheumatol. 2002;29:535–40.PubMed Salvarani C, Boiardi L, Casali B, Olivieri I, Ciancio G, Cantini F, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet’s disease. J Rheumatol. 2002;29:535–40.PubMed
23.
go back to reference Nagy G, Koncz A, Telarico T, Fernandez D, Ersek B, Buzás E, et al. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2010;12(3):210.PubMedCrossRef Nagy G, Koncz A, Telarico T, Fernandez D, Ersek B, Buzás E, et al. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2010;12(3):210.PubMedCrossRef
Metadata
Title
Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis
Authors
Young Ho Lee
Hye-Soon Lee
Sung Jae Choi
Jong Dae Ji
Gwan Gyu Song
Publication date
01-02-2012
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 2/2012
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0397-3

Other articles of this Issue 2/2012

Inflammation Research 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.